新闻动态
NEWS
1st Patient Dosed with Product BL0006 in China
Best-Link Dosed 1st Patient in Phase I Study with BL0020 in China
Best-Link Announces the First Patient Dosed with BL0020 in Australia
FDA Clearance of IND application for BL0020
NMPA Approved the IND application for BL0020
Best-Link closed RMB 182 million Series A financing
Best-Link closed RMB 80 million Series Angel financing